跳至主要内容
临床试验/ISRCTN60263108
ISRCTN60263108已完成未知

Biopsy diagnosis of prostate cancer in naïve patients. Comparison of target biopsy alone vs. target biopsy in addition to random: a prospective randomized trial

Ospedale San Luigi Gonzaga0 个研究点目标入组 384 人开始时间: 2022年3月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
384

研究概览

简要总结

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/36626117/ primary results (added 11/01/2023)

研究设计

研究类型
Interventional

入排标准

性别
Male

入选标准

  • 1. Age <75 years
  • 2. Negative history of previous prostate biopsies
  • 3. Suspected serum prostate-specific antigen (PSA) values <15 ng/ml
  • 4. Negative rectal examination (DRE)
  • 5. Positive multiparametric magnetic resonance imaging

排除标准

  • Contraindications to prostate biopsy (e.g., inability to discontinue anticoagulant therapy)

研究者

发起方
Ospedale San Luigi Gonzaga

相似试验

Biopsy diagnosis of prostate cancer in patients with... | 临床试验